Rhea-AI Summary
RTGN: A shareholder filed a Form 144 notice to sell up to 77,400 common shares with an aggregate market value of $247,680.00. The filing lists Alpine Securities Corporation as broker and targets an approximate sale date of November 10, 2025 on the OTCQB.
The filing notes 18,604,961 shares outstanding. It also discloses prior acquisitions and recent activity: the securities were acquired via warrant exercise dated 09/01/2018, with payment by check on 03/06/2019. Over the past three months, Bayern Capital LLC reported sales of common shares, including 8,000 for $30,718.67 on 10/24/2025, 10,100 for $36,800.27 on 10/27/2025, and 2,500 for $8,063.95 on 10/31/2025.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
FAQ
How many RetinalGenix Technologies (RTGN) SEC filings are available on StockTitan?
StockTitan tracks 11 SEC filings for RetinalGenix Technologies (RTGN), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.
When was the most recent SEC filing for RetinalGenix Technologies (RTGN)?
The most recent SEC filing for RetinalGenix Technologies (RTGN) was filed on November 7, 2025.